In our study, we show increased AT1R abundance in human invasive breast carcinoma biopsies, and in DMBA+MPA induced mouse mammary tumors; and that the systemic treatment with Losartan is effective in reducing tumor burden in mice. Here, AGTR1 is linked to invasive breast carcinoma.